Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke
Conclusion:
There may be a role for NOACs in stroke prevention and treatment beyond atrial fibrillation. Randomized controlled trials are needed to compare NOACs to current stroke prevention and treatment strategies in certain subgroups of patients with cerebrovascular disease.
Source: Neurology - Category: Neurology Authors: Yaghi, S., Kamel, H., Elkind, M. S. V. Tags: Stroke prevention, All Cerebrovascular disease/Stroke, Infarction, Cerebral venous thrombosis VIEWS & amp;amp; REVIEWS Source Type: research
More News: Atrial Fibrillation | Bleeding | Brain | Cervical Discectomy | Clinical Trials | Coumadin | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Patent Foramen Ovale | Stammer | Stroke | Study | Thrombosis | Vitamin K | Vitamins | Warfarin